The major advantages of the FATZO model are that it does not have the common obesity-producing monogenic (leptin) mutations, does not require high fat feeding to become obese and appears to develop a multi-faceted metabolic disease (obesity, hypertriglyceridemia, glucose intolerance, insulin resistance and hyperglycemia) very similar to the human disease. This evidence concerns the gene LEP and metabolic disease.